Accelerate Diagnostics, Inc. (AXDX)
USD 0.7
(-0.71%)
USD 0.7
(-0.71%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -49.77 Million USD | 14.64% |
| 2022 | -55.79 Million USD | 13.76% |
| 2021 | -59.59 Million USD | -15.13% |
| 2020 | -59.65 Million USD | 11.16% |
| 2019 | -67.55 Million USD | 10.08% |
| 2018 | -75.44 Million USD | -16.98% |
| 2017 | -61.33 Million USD | -0.71% |
| 2016 | -64.15 Million USD | -45.72% |
| 2015 | -43.68 Million USD | -42.93% |
| 2014 | -30.09 Million USD | -104.76% |
| 2013 | -14.91 Million USD | -1168.11% |
| 2012 | -3.15 Million USD | -600.17% |
| 2011 | -153.53 Thousand USD | -119.79% |
| 2010 | 873.28 Thousand USD | 338.84% |
| 2009 | -409.03 Thousand USD | 74.91% |
| 2008 | -1.43 Million USD | 24.57% |
| 2007 | -1.8 Million USD | 34.77% |
| 2006 | -2.71 Million USD | -46.4% |
| 2005 | -1.95 Million USD | -32.12% |
| 2004 | -1.49 Million USD | -34.82% |
| 2003 | -1.64 Million USD | -141.6% |
| 2002 | -598.91 Thousand USD | -365.55% |
| 2001 | -800.33 Thousand USD | 110.13% |
| 2000 | -1.42 Million USD | -1068.12% |
| 1999 | 175.64 Thousand USD | -95.86% |
| 1998 | 4.23 Million USD | 505.6% |
| 1997 | 1 Million USD | -46.15% |
| 1996 | 1.3 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -9.29 Million USD | -15.14% |
| 2024 Q2 | -7.72 Million USD | 25.64% |
| 2023 FY | - USD | 14.64% |
| 2023 Q1 | -14.79 Million USD | -13.99% |
| 2023 Q3 | -13.61 Million USD | -18.66% |
| 2023 Q4 | -7.58 Million USD | 44.33% |
| 2023 Q2 | -11.47 Million USD | 22.44% |
| 2022 FY | - USD | 13.76% |
| 2022 Q4 | -12.97 Million USD | 7.12% |
| 2022 Q3 | -13.97 Million USD | 18.85% |
| 2022 Q1 | -15.3 Million USD | 18.69% |
| 2022 Q2 | -17.22 Million USD | -12.5% |
| 2021 Q1 | -19.33 Million USD | -35.84% |
| 2021 FY | - USD | -15.13% |
| 2021 Q2 | -16.9 Million USD | 12.53% |
| 2021 Q4 | -18.82 Million USD | -35.33% |
| 2021 Q3 | -13.91 Million USD | 17.73% |
| 2020 Q3 | -14.33 Million USD | 2.3% |
| 2020 Q4 | -14.23 Million USD | 0.7% |
| 2020 FY | - USD | 11.16% |
| 2020 Q1 | -16.67 Million USD | 2.2% |
| 2020 Q2 | -14.67 Million USD | 12.03% |
| 2019 Q2 | -16.66 Million USD | 3.98% |
| 2019 Q3 | -16.98 Million USD | -1.92% |
| 2019 Q1 | -17.35 Million USD | 4.05% |
| 2019 FY | - USD | 10.08% |
| 2019 Q4 | -17.05 Million USD | -0.39% |
| 2018 Q2 | -19.66 Million USD | 1.58% |
| 2018 FY | - USD | -16.98% |
| 2018 Q4 | -18.08 Million USD | -1.65% |
| 2018 Q3 | -17.79 Million USD | 9.52% |
| 2018 Q1 | -19.98 Million USD | -29.49% |
| 2017 Q1 | -13.77 Million USD | 9.87% |
| 2017 Q2 | -15.72 Million USD | -14.16% |
| 2017 Q3 | -17.27 Million USD | -9.84% |
| 2017 Q4 | -15.43 Million USD | 10.67% |
| 2017 FY | - USD | -0.71% |
| 2016 Q1 | -14.57 Million USD | -22.41% |
| 2016 Q4 | -15.28 Million USD | 8.23% |
| 2016 Q2 | -17.14 Million USD | -17.62% |
| 2016 Q3 | -16.65 Million USD | 2.83% |
| 2016 FY | - USD | -45.72% |
| 2015 Q3 | -10.71 Million USD | 9.52% |
| 2015 Q4 | -11.9 Million USD | -11.09% |
| 2015 FY | - USD | -42.93% |
| 2015 Q1 | -9.21 Million USD | -9.47% |
| 2015 Q2 | -11.84 Million USD | -28.53% |
| 2014 Q1 | -5.59 Million USD | -10.53% |
| 2014 Q4 | -8.41 Million USD | 1.64% |
| 2014 Q3 | -8.55 Million USD | -7.04% |
| 2014 FY | - USD | -104.76% |
| 2014 Q2 | -7.99 Million USD | -42.92% |
| 2013 Q2 | -3.68 Million USD | -47.78% |
| 2013 Q3 | -3.69 Million USD | -0.15% |
| 2013 FY | - USD | -1168.11% |
| 2013 Q4 | -5.06 Million USD | -37.03% |
| 2013 Q1 | -2.49 Million USD | 38.19% |
| 2012 Q2 | -157.61 Thousand USD | 56.58% |
| 2012 Q3 | -993.2 Thousand USD | -530.15% |
| 2012 FY | - USD | -600.17% |
| 2012 Q4 | -4.03 Million USD | -306.48% |
| 2012 Q1 | -362.97 Thousand USD | -22.85% |
| 2011 FY | - USD | -119.79% |
| 2011 Q4 | -295.47 Thousand USD | 18.14% |
| 2011 Q2 | -191.36 Thousand USD | -153.34% |
| 2011 Q1 | -75.53 Thousand USD | -6590.52% |
| 2011 Q3 | -360.93 Thousand USD | -88.62% |
| 2010 Q2 | 1.89 Million USD | 652.9% |
| 2010 Q4 | -1129.00 USD | -101.13% |
| 2010 Q3 | 99.92 Thousand USD | -94.73% |
| 2010 FY | - USD | 338.84% |
| 2010 Q1 | -342.79 Thousand USD | -2.3% |
| 2009 Q4 | -335.08 Thousand USD | 8.96% |
| 2009 FY | - USD | 74.91% |
| 2009 Q1 | -172.54 Thousand USD | -2390.14% |
| 2009 Q2 | -120.43 Thousand USD | 30.2% |
| 2009 Q3 | -368.06 Thousand USD | -205.62% |
| 2008 Q3 | -55.72 Thousand USD | 84.46% |
| 2008 Q1 | -276.72 Thousand USD | 4.97% |
| 2008 FY | - USD | 24.57% |
| 2008 Q4 | -6929.00 USD | 87.57% |
| 2008 Q2 | -358.61 Thousand USD | -29.59% |
| 2007 Q1 | -459.89 Thousand USD | -181.59% |
| 2007 Q3 | -491.08 Thousand USD | -21.24% |
| 2007 Q2 | -405.05 Thousand USD | 11.93% |
| 2007 FY | - USD | 34.77% |
| 2007 Q4 | -291.19 Thousand USD | 40.7% |
| 2006 Q4 | 563.64 Thousand USD | 196.84% |
| 2006 Q3 | -582.04 Thousand USD | -1.38% |
| 2006 Q2 | -574.12 Thousand USD | 26.07% |
| 2006 Q1 | -776.57 Thousand USD | 1.5% |
| 2006 FY | - USD | -46.4% |
| 2005 Q2 | 1.99 Million USD | 484.08% |
| 2005 Q3 | -741.08 Thousand USD | -137.22% |
| 2005 Q1 | -518.37 Thousand USD | -83.48% |
| 2005 FY | - USD | -32.12% |
| 2005 Q4 | -788.4 Thousand USD | -6.39% |
| 2004 Q2 | -486.57 Thousand USD | -109.02% |
| 2004 Q4 | -282.51 Thousand USD | 38.99% |
| 2004 Q1 | -232.78 Thousand USD | 37.55% |
| 2004 Q3 | -463.05 Thousand USD | 4.83% |
| 2004 FY | - USD | -34.82% |
| 2003 Q2 | -616.04 Thousand USD | -73.43% |
| 2003 FY | - USD | -141.6% |
| 2003 Q1 | -214.49 Thousand USD | -17.2% |
| 2003 Q3 | -427.76 Thousand USD | 12.01% |
| 2003 Q4 | -404.99 Thousand USD | 6.23% |
| 2002 Q1 | -133.83 Thousand USD | 63.68% |
| 2002 FY | - USD | -365.55% |
| 2002 Q4 | -242.34 Thousand USD | -30.47% |
| 2002 Q3 | -180.39 Thousand USD | -368.84% |
| 2002 Q2 | -782.00 USD | 174.24% |
| 2001 Q2 | -216.5 Thousand USD | 283.32% |
| 2001 Q3 | -254.58 Thousand USD | -215.33% |
| 2001 Q4 | -209.71 Thousand USD | -17.29% |
| 2001 FY | - USD | 110.13% |
| 2001 Q1 | -165.46 Thousand USD | 61.58% |
| 2000 Q3 | -122.37 Thousand USD | 90.41% |
| 2000 FY | - USD | -1068.12% |
| 2000 Q2 | -603.81 Thousand USD | -15.67% |
| 2000 Q1 | -572.57 Thousand USD | -65.83% |
| 2000 Q4 | -295.99 Thousand USD | 137.46% |
| 1999 FY | - USD | -95.86% |
| 1999 Q4 | -406.98 Thousand USD | -112.5% |
| 1999 Q3 | -191.51 Thousand USD | -198.62% |
| 1999 Q2 | 194.19 Thousand USD | 253.21% |
| 1999 Q1 | -126.75 Thousand USD | -2163.05% |
| 1998 Q1 | 1.76 Million USD | -10.89% |
| 1998 Q4 | 6144.00 USD | -93.98% |
| 1998 Q3 | 102.05 Thousand USD | 116.89% |
| 1998 FY | - USD | 505.6% |
| 1998 Q2 | -604.08 Thousand USD | -134.3% |
| 1997 Q1 | 300 Thousand USD | 400.0% |
| 1997 Q2 | 400 Thousand USD | 0.0% |
| 1997 Q3 | 1.1 Million USD | 268.7% |
| 1997 Q4 | 1.97 Million USD | 78.67% |
| 1997 FY | - USD | -46.15% |
| 1996 Q2 | 600 Thousand USD | 100.0% |
| 1996 Q3 | 300 Thousand USD | -50.0% |
| 1996 FY | - USD | 0.0% |
| 1996 Q4 | -100 Thousand USD | -133.33% |
| 1996 Q1 | 300 Thousand USD | 50.0% |
| 1995 Q3 | 200 Thousand USD | 0.0% |
| 1995 Q4 | 200 Thousand USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | -269.029% |
| Cerus Corporation | -26.53 Million USD | -87.56% |
| OrthoPediatrics Corp. | -8.38 Million USD | -493.855% |
| PetVivo Holdings, Inc. | -10.49 Million USD | -374.258% |
| Talis Biomedical Corporation | -66.04 Million USD | 24.641% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | -198.477% |
| Inogen, Inc. | -45.67 Million USD | -8.958% |
| Spectral AI, Inc. | -12.26 Million USD | -305.896% |
| Nano-X Imaging Ltd. | -47.69 Million USD | -4.357% |
| CVRx, Inc. | -38.73 Million USD | -28.504% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -1310.743% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | -311.093% |
| Orthofix Medical Inc. | -86.98 Million USD | 42.782% |
| Venus Concept Inc. | -26.11 Million USD | -90.599% |
| Bioventus Inc. | -23.07 Million USD | -115.739% |
| BrainsWay Ltd. | -2.31 Million USD | -2053.656% |
| Envoy Medical, Inc. | -18.23 Million USD | -172.897% |
| electroCore, Inc. | -17.76 Million USD | -180.242% |
| IceCure Medical Ltd | -15.25 Million USD | -226.303% |
| Lucid Diagnostics Inc. | -49.75 Million USD | -0.04% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | -195.277% |
| MaxCyte, Inc. | -44.12 Million USD | -12.788% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | -323.367% |
| Nexalin Technology, Inc. | -5.69 Million USD | -774.396% |
| PAVmed Inc | -75.74 Million USD | 34.289% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 7.417% |
| RxSight, Inc. | -41.03 Million USD | -21.283% |
| Sight Sciences, Inc. | -49.41 Million USD | -0.72% |
| SI-BONE, Inc. | -34.44 Million USD | -44.49% |
| TELA Bio, Inc. | -40.63 Million USD | -22.489% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 14.627% |
| Treace Medical Concepts, Inc. | -39 Million USD | -27.592% |
| LivaNova PLC | 39.01 Million USD | 227.566% |
| 908 Devices Inc. | -34.02 Million USD | -46.278% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 54.996% |
| Nemaura Medical Inc. | -7.28 Million USD | -583.005% |
| NeuroPace, Inc. | -22.83 Million USD | -117.969% |
| LENSAR, Inc. | -8.71 Million USD | -471.161% |
| Apyx Medical Corporation | -18.11 Million USD | -174.796% |
| Cutera, Inc. | -136.56 Million USD | 63.554% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -1372.515% |
| BioSig Technologies, Inc. | -28.15 Million USD | -76.8% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 2078.18% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | -137.129% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 112.976% |
| Axonics, Inc. | 7.77 Million USD | 740.141% |
| Outset Medical, Inc. | -153.78 Million USD | 67.637% |
| IRIDEX Corporation | -7.44 Million USD | -568.247% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 49.262% |
| IRadimed Corporation | 20.8 Million USD | 339.276% |
| Tivic Health Systems, Inc. | -8.06 Million USD | -517.353% |
| INVO Bioscience, Inc. | -6.88 Million USD | -623.413% |
| Telesis Bio, Inc. | -40.49 Million USD | -22.913% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 235.701% |
| Varex Imaging Corporation | 67.2 Million USD | 174.064% |
| Quipt Home Medical Corp. | 44.07 Million USD | 212.934% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -357.875% |
| Pulmonx Corporation | -55.09 Million USD | 9.658% |
| Dynatronics Corporation | -976 Thousand USD | -4999.446% |
| Modular Medical, Inc. | -17.1 Million USD | -191.007% |
| ReShape Lifesciences Inc. | -14.48 Million USD | -243.604% |
| Semler Scientific, Inc. | 23.58 Million USD | 310.992% |
| InMode Ltd. | 196.28 Million USD | 125.357% |
| Bruker Corporation | 599 Million USD | 108.309% |
| Cytosorbents Corporation | -28.81 Million USD | -72.751% |
| DexCom, Inc. | 916.7 Million USD | 105.429% |
| Align Technology, Inc. | 799.03 Million USD | 106.229% |
| Viveve Medical, Inc. | -20.61 Million USD | -141.408% |
| ZimVie Inc. | 91.07 Million USD | 154.65% |
| Movano Inc. | -29.12 Million USD | -70.888% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -1029.106% |
| Nexalin Technology, Inc. | -5.69 Million USD | -774.396% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -1310.743% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 74.431% |
| Profound Medical Corp. | -27.12 Million USD | -83.498% |
| Insulet Corporation | 323.6 Million USD | 115.38% |
| enVVeno Medical Corporation | -25.01 Million USD | -98.941% |
| Surmodics, Inc. | 1.18 Million USD | 4289.478% |
| iCAD, Inc. | -6.56 Million USD | -658.126% |
| Nuwellis, Inc. | -16.35 Million USD | -204.298% |
| Biotricity, Inc. | -8.82 Million USD | -463.769% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 48.617% |
| Aethlon Medical, Inc. | -11.84 Million USD | -320.04% |
| InspireMD, Inc. | -20.91 Million USD | -138.013% |
| PAVmed Inc. | -75.74 Million USD | 34.289% |
| BIOLASE, Inc. | -15.13 Million USD | -228.76% |
| Beyond Air, Inc. | -59.03 Million USD | 15.687% |
| FONAR Corporation | 28.25 Million USD | 276.171% |
| AxoGen, Inc. | -13.32 Million USD | -273.432% |
| Vivani Medical, Inc. | -26.6 Million USD | -87.053% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 302.808% |
| Inari Medical, Inc. | 7.11 Million USD | 799.719% |
| UFP Technologies, Inc. | 72.74 Million USD | 168.42% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -1369.998% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | -708.496% |
| Tenon Medical, Inc. | -15.52 Million USD | -220.524% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | -226.025% |
| Co-Diagnostics, Inc. | -41.47 Million USD | -20.0% |
| AdaptHealth Corp. | -171.09 Million USD | 70.91% |
| Sintx Technologies, Inc. | -6.6 Million USD | -654.106% |
| NanoVibronix, Inc. | -3.43 Million USD | -1348.937% |
| Quanterix Corporation | -38.08 Million USD | -30.674% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -357.875% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 166003.333% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 82.05% |
| TransMedics Group, Inc. | -7.6 Million USD | -554.623% |
| ReWalk Robotics Ltd. | -21.76 Million USD | -128.674% |
| NeuroMetrix, Inc. | -7.09 Million USD | -601.414% |
| Hyperfine, Inc. | -47.06 Million USD | -5.758% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 14.64% |
| Biomerica, Inc. | -5.99 Million USD | -730.486% |
| Bone Biologics Corporation | 479.57 Thousand USD | 10478.212% |
| AVITA Medical, Inc. | -39.56 Million USD | -25.787% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | -442.586% |
| Silk Road Medical, Inc | -45.08 Million USD | -10.406% |